Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-01 4:30 pm Purchase | 2026-03-31 | 13D | CONNECT BIOPHARMA HOLDINGS LIM CNTB | Panacea Innovation Limited | 13,160,000 21.200% | 1,160,000 (+9.67%) | Filing History |
| 2026-01-14 9:20 pm Sale | 2026-01-12 | 13D | ATARA BIOTHERAPEUTICS INC ATRA | Panacea Innovation Limited | 1,632,345 19.990% | -80,555 (-4.70%) | Filing History |
| 2025-12-17 4:15 pm Purchase | 2025-12-16 | 13D | CASI PHARMACEUTICALS HLDGS INC CASIF | Panacea Innovation Limited | 4,651,527 22.500% | 989,956 (+27.04%) | Filing History |
| 2025-11-26 4:30 pm Sale | 2025-11-24 | 13D | CONNECT BIOPHARMA HOLDINGS LIM CNTB | Panacea Innovation Limited | 12,000,000 21.500% | -1,950,000 (-13.98%) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | ADAGENE INC ADS ADAG | Panacea Innovation Limited | 2,250,000 3.800% | -787,500 (-25.93%) | Filing History |
| 2025-09-26 6:45 pm Purchase | 2025-09-26 | 13D | CASI PHARMACEUTICALS HLDGS INC CASIF | Panacea Innovation Limited | 3,661,571 19.900% | 3,661,571 (New Position) | Filing History |
| 2025-08-19 8:15 pm Purchase | 2025-08-15 | 13D | ATARA BIOTHERAPEUTICS INC ATRA | Panacea Innovation Limited | 1,712,900 20.000% | 74,335 (+4.54%) | Filing History |
| 2025-07-21 09:00 am Purchase | 2025-07-21 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,950,000 25.100% | 540,000 (+4.03%) | Filing History |
| 2025-05-21 6:00 pm Purchase | 2025-05-16 | 13D | ATARA BIOTHERAPEUTICS INC ATRA | Panacea Innovation Limited | 1,638,565 19.990% | 1,088,565 (+197.92%) | Filing History |
| 2025-02-14 4:30 pm Purchase | 2024-12-31 | 13G | ADAGENE INC ADS ADAG | Panacea Innovation Limited | 3,037,500 5.500% | 3,037,500 (New Position) | Filing History |
| 2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Panacea Innovation Limited | 2,200,000 2.600% | -2,000,000 (-47.62%) | Filing History |
| 2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Panacea Innovation Limited | 0 0.000% | -5,500,000 (Position Closed) | Filing History |
| 2025-02-06 6:34 pm Purchase | 2025-01-30 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Panacea Innovation Limited | 550,000 9.500% | 550,000 (New Position) | Filing History |
| 2024-11-01 8:30 pm Purchase | 2024-10-25 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Panacea Innovation Limited | 5,500,000 9.980% | 5,500,000 (New Position) | Filing History |
| 2024-07-01 4:16 pm Purchase | 2024-06-27 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,410,000 24.300% | 1,410,000 (+11.75%) | Filing History |
| 2024-03-11 08:44 am Purchase | 2024-03-08 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Panacea Innovation Limited | 4,200,000 6.200% | 4,200,000 (New Position) | Filing History |
| 2024-02-27 9:00 pm Purchase | 2024-02-23 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 12,000,000 21.800% | 3,100,000 (+34.83%) | Filing History |
| 2024-02-13 4:30 pm Purchase | 2024-02-12 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 8,900,000 16.200% | 8,900,000 (New Position) | Filing History |